Skip to NavigationSkip to content

News

The coronavirus outbreak has changed the way that the world prioritises healthcare resources, and lay bare just how unprepared many countries were in...
The British Heart Foundation is funding a trial for a drug that could prevent life-threatening blood clots that have been seen in the lungs of...
New Zealand has reported its first new case of coronavirus after two COVID-19 positive women arrived in the country from Britain.
As more than 130 efforts to develop an effective vaccine against the novel coronavirus continue to roll on, Beijing-based firm Sinovac has revealed...
The FDA has revoked its emergency approval of hydroxychloroquine and chloroquine due to health risks and a lack of effectiveness in treating COVID-19.
Janssen has revealed new data on its interleukin (IL)-23 inhibitor Tremfya (guselkumab) at the American Academy of Dermatology (AAD) virtual event...
China reported its highest amount of coronavirus cases in months as a new outbreak has been linked to a food market in Beijing.
Multiple European governments have been involved in a deal with AstraZeneca to access a supply of the British drugmakers' potential vaccine against...
Roche's Rozlytrek (entrectinib) has secured recommendation for NHS use in England and Wales after NICE backed the drug in final draft guidance for...
AbbVie have announced positive results from its latest Phase 3 clinical trial where Venclexta plus azacitidine improved survival and remission rates...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches